Opioid-induced neurotoxicity after opioid conversion to methadone in patients with cancer pain using the stop-and-go method: A multicenter retrospective cohort study
Authors:
- Agnès Calsina-BernaACAgnès Calsina-Berna
- Jesús González-BarboteoJGJesús González-Barboteo
- Anna EsteveAEAnna Esteve
- Silvia Llorens TorroméSTSilvia Llorens Torromé
- Gemma Sanclemente JuarrosGJGemma Sanclemente Juarros
- Montserrat Bleda PérezMPMontserrat Bleda Pérez
- Irene Carré MirandaIMIrene Carré Miranda
- Margarita Alvaro PardoMPMargarita Alvaro Pardo
- Lina Maria Nitola MendozaLMLina Maria Nitola Mendoza
- Paula Garrido BallartPBPaula Garrido Ballart
- Roser Cuadros-MargaritRCRoser Cuadros-Margarit
- Montse Olmo PlazaMPMontse Olmo Plaza
- 11 January 2026
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (2) , 83
Abstract
Purpose To describe the frequency of opioid-induced neurotoxicity (OINT) after opioid conversion (OC) to methadone using the Stop-and-Go (SAG) method in cancer patients with inadequate pain control, and to identify factors associated with OINT. Methods This multicenter retrospective cohort study included adult hospitalized cancer patients who underwent OC to methadone using the SAG method for poor pain control at two comprehensive cancer centers between January 2018 and October 2022. Patients were monitored 14 days after OC, and variables related to OINT were analyzed. Ethical approval was obtained. Results A total of 372 patients underwent OC using the SAG method. The mean morphine-equivalent daily dose (MEDD) before OC was 212.2 mg (SD 128). OINT occurred in 70 patients (18.8%). Methadone was permanently discontinued in 2 patients (2.8%) and temporarily withheld in 7, while 61 were managed with hydration and a 15–20% methadone dose reduction. No patient required naloxone. OINT was less frequent in younger patients (mean age 59.4 vs. 63 years; p = 0.032) and showed a trend toward lower incidence in women (13% vs.22%; p = 0.065). Preexisting cognitive impairment or delirium was associated with OINT (52.4% vs.16.8%; p < 0.001). The mean time from OC to death was shorter among patients with OINT (2.1 months; SD 3.9) compared with those without OINT (3.6 months; SD 6.4; p = 0.012). Conclusion OC to methadone using the SAG method in patients with low-to-moderate MEDD was associated with a relatively low OINT frequency (18.8%). These findings suggest that SAG method in patients with low-to-moderate MEDD before OC may be safe, particularly for younger patients and those without cognitive impairment.Keywords
This publication has 28 references indexed in Scilit:
- Effectiveness of opioid rotation in the control of cancer pain: The ROTODOL StudyJournal of Opioid Management, 2014
- Therapeutic Challenges in Cancer Pain Management: A Systematic Review of MethadoneJournal of Pain & Palliative Care Pharmacotherapy, 2014
- Methadone Safety: A Clinical Practice Guideline From the American Pain Society and College on Problems of Drug Dependence, in Collaboration With the Heart Rhythm SocietyThe Journal of Pain, 2014
- Switching Methadone: A 10-Year Experience of 345 Patients in an Acute Palliative Care UnitPain Medicine, 2012
- Rotación de opioides: una alternativa en el tratamiento del dolor refractario en pacientes con cáncerMedicina Clinica, 2010
- The role of methadone in cancer pain treatment - a reviewInternational Journal Of Clinical Practice, 2009
- Opioid switching: A systematic and critical reviewCancer Treatment Reviews, 2006
- The rediscovery of methadone for cancer pain managementMedical Journal of Australia, 2000
- Differences in the Ratios of Morphine to Methadone in Patients with Neuropathic Pain Versus Non-Neuropathic PainJournal of Pain and Symptom Management, 1999
- Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: Comparison of two clinical experiences1998